Drug InfoNet.com
DrugInfoNet Home Page FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Search
Powered By HealthLine
Special Offers
Health Tools
 High Blood Pressure Q&A
 Causes and Risks of HBP
 Check Your Cholesterol
 Blood Pressure Quiz
 Understanding Blood Pressure
Featured Conditions
 Diabetes
 Diabetes and Teens
 High Blood Pressure
 Cholesterol
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today



Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine
 Printer Friendly  Send to a Friend

A Hope: Contaminant-Free Synthetic Heparin

Team of chemists makes blood thinner in lab, but hopes for large-scale production

By Ed Edelson
HealthDay Reporter


Related Encyclopedia
 border=
Aneurysms
Angina Pectoris
Angiogram
Angiography
More...

Related Healthscout Videos
 border=
Importance of Good Nutrition
Controlling Incontinence
Preventing Heart Disease the Easy Way
Lifestyle Changes for Heart Disease Prevention and Treatment
More...

Related Animations
 border=
Angioplasty
Coronary Bypass Surgery
What is a Heart Attack?
What is Cholesterol?
More...

Related Drug Information
 border=
Accupril
Altace
Avapro
Cartia XT
More...

Related News Articles
 border=
High Blood Pressure Stalks Many Americans
Vitamin D Deficit Could Lead to Heart Woes
Smokeout '08: The Perfect Time to Quit
Specialized Stroke Care Improves Outcomes
More...

MONDAY, Aug. 18 (HealthDay News) -- Robert J. Linhardt is a chemist with a dream: making the blood-thinner heparin by the bucketful without using animal tissue.

It's a dream that has taken on urgency this year, as the U.S. Food and Drug Administration attributed more than 80 American deaths and hundreds of illnesses to contaminated heparin from the conventional source -- pig intestines processed in China.

Text Continues Below



That processing often is done in small mom-and-pop workshops, a situation conducive to contamination, said Linhardt, a professor of chemistry, biology and chemical engineering at Rensselaer Polytechnic Institute in Troy, N.Y.

"Our group has been working on understanding heparin biosynthesis for almost 30 years," he said. "We are working on what might be the next generation of heparin production, with no animal source."

Heparin has been made synthetically in the recent past but only in microscopically small amounts. Scheduled to speak Sunday at the American Chemical Society annual meeting, in Philadelphia, Linhardt described a new method of heparin biosynthesis that has produced amounts measured in milligrams. But, it's his hope that production can be scaled up a million-fold.

The process starts with a polysaccharide, a chain of carbohydrate units, extracted from the bacterium E. coli. "We treat it to reduce the molecular size, then subject it to enzymatic steps to convert it to heparin," he explained. "We use recombinant enzymes that are part of the natural pathway for heparin synthesis."

Now comes the difficult part, "scaling up the process so it is commercially viable," Linhardt said. "We are now working with one liter amounts. There are million-liter fermenters. We have to scale up three orders of magnitude, which is pretty daunting but not impossible."

Heparin is given by injection to prevent blood clotting during heart surgery, kidney dialysis and other procedures. Having a completely synthetic heparin would eliminate any worries about the kind of contamination that occurred this year, Linhardt said.

Page:  1 | 2 | Next >>

Copyright © 2008 ScoutNews, LLC. All rights reserved.
Last updated 8/18/2008

Related Links
 border=
From Healthscout's partner site on breast cancer, MyBreastCancerNetwork.com
VIDEO: Chemo booster cuts treatment time by two months
SYMPTOMS: Learn what to look for and what the symptoms mean
PROGNOSIS: Early detection and new treatments improve survival rates





SOURCES: Robert J. Linhardt, Ph.D., professor of chemistry, biology and chemical engineering, Rensselaer Polytechnic Institute, Troy, N.Y.; Aug. 17, 2008, presentation, American Chemical Society annual meeting, Philadelphia


We comply with the HONcode standard for trustworthy health
information:
verify here.
About The HealthScout Network Contact Us
Copyright © 2001-2008. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy  Terms of Service    

FAQ Drug Info Disease Info Manufacturer Info Health Care News Health Info Become Panelist Health Care Orgs Medical References Government Sites Hospital Sites Medical Schools
Contact | Site Map | Search | Disclaimer | Mission Statement

© 1996-2003 DRUG INFONET, Inc. All rights reserved.